Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Recruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The record history now shows the latest revision as v3.6.0 and removes the earlier v3.5.5 entry from the history.
    Difference
    0.5%
    Check dated 2026-06-14T01:16:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the history, replacing the previous v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-06T20:55:27.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.4' was added to the study record history, replacing the previous 'Revision: v3.5.3'.
    Difference
    0.1%
    Check dated 2026-05-16T10:24:36.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A minor interface/version update is reflected by changing the displayed “Revision” from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T05:21:37.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-18T00:20:43.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    A new revision (v3.5.0) was added to the record history and an older revision (v3.4.3) was removed.
    Difference
    0.1%
    Check dated 2026-03-20T03:28:15.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.